November 2025 in “Frontiers in Medicine” The SAALIQ is a reliable tool for measuring the impact of alopecia areata on Spanish-speaking patients' quality of life.
9 citations
,
July 2010 in “British Journal of Dermatology” The document suggests a rare skin condition might be caused by a genetic phenomenon.
1 citations
,
January 2014 in “International Journal of Trichology” A patient with a rare hair condition and skin disorder showed hair improvement after treatment.
2 citations
,
March 2024 in “Egyptian Journal of Health Care” Mindfulness intervention greatly improves quality of life and reduces distress in women with breast cancer.
February 2024 in “Cureus” Pilomatrixoma should be considered for nodular lesions in adults.
Human placental extract effectively and safely improves melasma, ulcers, and alopecia areata.
January 2022 in “International Journal of Clinical Oncology and Cancer Research” Consider Castleman's disease in similar cases; histology and steroids help diagnose and manage it.
4 citations
,
September 2020 in “Cell division” XMU-MP-1 stops cell growth in a human mini-organ and reduces the effectiveness of the chemotherapy drug paclitaxel.
May 2025 in “Journal of the European Academy of Dermatology and Venereology” Etrasimod is safe but not effective for severe alopecia areata, though it may help milder cases.
4 citations
,
December 2019 in “Dermatologic Therapy” Hair enzyme activity predicts minoxidil success in Brazilian women with hair loss.
10 citations
,
June 2006 in “Clinical and experimental dermatology” Laser hair removal greatly improves quality of life.
1 citations
,
October 2010 in “Series in cosmetic and laser therapy” Mesotherapy is a minimally invasive treatment with potential benefits and risks, requiring standardized practices and further investigation.
3 citations
,
January 2023 in “Journal of Cutaneous and Aesthetic Surgery” Intradermal PRP significantly improved melasma in dark skin, with lasting results and no relapse after 3 months.
15 citations
,
December 2013 in “Clinical Cosmetic and Investigational Dermatology” MAGP-1 decreases with age, leading to weaker, sagging skin.
16 citations
,
January 1985 in “Hormone research” The treatment slowed hair growth but didn't always match the improvements seen by doctors or patients.
97 citations
,
January 2006 in “Dermatology” imTA and pulse therapy are effective for alopecia areata with manageable side effects, but relapse rates need improvement.
7 citations
,
January 2013 in “Supportive care in cancer” Hair mass index is a precise way to measure hair loss in chemotherapy patients.
Mesotherapy is more effective and preferred for female hair loss than topical minoxidil.
1 citations
,
January 2016 in “Klinicheskaya dermatologiya i venerologiya” 13 citations
,
January 2021 in “The American journal of gastroenterology” Sirolimus effectively reduces lesions and improves quality of life in Blue Rubber Bleb Nevus Syndrome with manageable side effects.
April 2018 in “Journal of Investigative Dermatology” The new protocol using Cellutome™ and RCM safely assesses wound healing in detail.
18 citations
,
February 2001 in “Der Hautarzt” A woman with myotonic dystrophy had multiple skin tumors on her scalp, suggesting a genetic link.
2 citations
,
July 2025 in “Scientific Reports” Dermatological diseases affect women's work performance more than men's.
49 citations
,
July 1994 in “British journal of dermatology/British journal of dermatology, Supplement” Some children with methylmalonic and propionic acidaemias have skin problems related to their condition and diet.
5 citations
,
May 2024 in “Australasian Journal of Dermatology” May 2025 in “American Journal of Veterinary Research” Photobiomodulation did not significantly improve hair density in dogs with alopecia X.
8 citations
,
August 2024 in “Clinical and Experimental Dermatology” 1 citations
,
June 2022 in “Photobiomodulation, photomedicine, and laser surgery” Photobiomodulation increases hair density in 5 weeks for androgenetic alopecia.
September 2019 in “Journal of Investigative Dermatology” Vitiligo patients are willing to pay the most for treatment, regardless of disease severity.
July 2024 in “Journal of Investigative Dermatology” Topical melatonin may reduce skin aging by inhibiting certain cellular pathways.